Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroprotective agents in acute ischemic stroke.

D Sareen1

  • 1Department of Neurology, St. Stephen's Hospital, Tis Hazari, New Delhi.

The Journal of the Association of Physicians of India
|June 1, 2002
PubMed
Summary

Neuroprotection aims to prevent delayed brain injury after ischemia by targeting the ischemic cascade. Despite extensive research and numerous drug trials, neuroprotective agents have yielded mixed results, highlighting the need for further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulinoma presenting with dementia and hemiplegia.

Neurology India·2018
Same author

Evaluation of retinopathy of prematurity screening in reverse Kangaroo Mother Care: a pilot study.

Eye (London, England)·2015
Same author

Pneumatization correlated to myringoplasty and tubal function.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2012
Same author

Primary tuberculosis of the tongue: a rare nodular presentation.

British dental journal·2006
Same author

Primary parotid tuberculosis: varied clinical presentations.

Oral diseases·2006
Same author

Primary tuberculous osteomyelitis of zygoma.

International journal of oral and maxillofacial surgery·2005

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Delayed neuronal injury following ischemia is a key concept in neuroprotection.
  • The "ischemic cascade" presents multiple therapeutic targets for intervention.
  • Understanding these mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To review the therapeutic strategies and clinical trial outcomes for neuroprotection.
  • To explore the ongoing discovery of mechanisms underlying focal ischemic injury.
  • To identify future therapeutic perspectives for clinical neuroprotection.

Main Methods:

  • Review of existing literature on neuroprotection and ischemic injury.
  • Analysis of clinical trial data for various neuroprotective agents.
  • Exploration of emerging research on the mechanisms of focal ischemia.

Main Results:

  • Ten classes of neuroprotective agents have undergone Phase III efficacy trials.
  • Clinical trial results for these agents have been mixed.
  • Ongoing research continues to uncover new mechanisms of ischemic injury.

Conclusions:

  • Neuroprotection strategies targeting the ischemic cascade have shown limited success to date.
  • Further research into the underlying mechanisms of ischemic injury is essential.
  • New therapeutic approaches for neuroprotection may emerge from continued scientific discovery.

Related Experiment Videos